UK markets closed

Editas Medicine, Inc. (0IFK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
34.07-7.58 (-18.20%)
At close: 6:42PM BST
Full screen
Previous close41.65
Open38.17
Bid0.00 x N/A
Ask0.00 x N/A
Day's range33.75 - 38.17
52-week range33.75 - 38.17
Volume3,070
Avg. volumeN/A
Market cap1.669B
Beta (5Y monthly)2.01
PE ratio (TTM)N/A
EPS (TTM)-1.98
Earnings date06 May 2021 - 11 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks
    Motley Fool

    Nasdaq Stays Flat as Workhorse Drives Higher, Editas Sinks

    The stock market moved higher again on Friday, although the Nasdaq Composite (NASDAQINDEX: ^IXIC) struggled to climb into positive territory. As of just before 3 p.m. EDT, the Nasdaq was up less than 0.1%. Investors have been happy with the returns that the Nasdaq and other major market benchmarks have generated over the past year, but they've been increasingly nervous about whether the stock market is moving into bubble territory.

  • Why Editas Medicine Stock Is Getting Crushed Today
    Motley Fool

    Why Editas Medicine Stock Is Getting Crushed Today

    Shares of gene-editing specialist Editas Medicine (NASDAQ: EDIT) are falling sharply on Friday and were down by 16.7% as of 2:02 p.m. EDT. Goldman Sachs analyst Madhu Kumar initiated coverage of Editas Medicine with a sell rating Friday. Editas Medicine's share price as of the closing of business day yesterday was $40.98.

  • 3 Biotech Stocks Ripe for Spring Portfolio Cleaning
    Motley Fool

    3 Biotech Stocks Ripe for Spring Portfolio Cleaning

    This April, many previous growth stocks have cooled, and the biotech sector is no exception. FibroGen (NASDAQ: FGEN), Novavax (NASDAQ: NVAX), and Editas Medicine (NASDAQ: EDIT) have all taken a beating for various reasons. It usually is not a reassuring sign to see that, right before going in front of the U.S. Food and Drug Administration (FDA) for review, a company wants to clarify prior data in regards to cardiovascular safety.